• No results found

Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy

N/A
N/A
Protected

Academic year: 2021

Share "Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy"

Copied!
10
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced

stage HNSCC patients treated with chemoradiotherapy

van der Heijden, Martijn; Essers, Paul B M; Verhagen, Caroline V M; Willems, Stefan M;

Sanders, Joyce; de Roest, Reinout H; Vossen, David M; Leemans, C René; Verheij, Marcel;

Brakenhoff, Ruud H

Published in:

Radiotherapy and Oncology

DOI:

10.1016/j.radonc.2020.05.013

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van der Heijden, M., Essers, P. B. M., Verhagen, C. V. M., Willems, S. M., Sanders, J., de Roest, R. H., Vossen, D. M., Leemans, C. R., Verheij, M., Brakenhoff, R. H., van den Brekel, M. W. M., & Vens, C. (2020). Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. Radiotherapy and Oncology, 147, 186-194.

https://doi.org/10.1016/j.radonc.2020.05.013

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)

Referenties

GERELATEERDE DOCUMENTEN

Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab.. Joseph, Jeroen Elassaiss-Schaap,

This study is the first study, to the best of my knowledge, which has explored gender- and parent participation differences, in the effect of Mindful Parenting Training on

‘We zijn verontrust dat het volgens sommige mensen blijkbaar niet is toegestaan dat een wetenschapper in een persoonlijk verhaal zijn opinie geeft naar aanleiding van zijn

Wanneer een schaaltje in een looplijn van de dieren wordt geplaatst, bijvoorbeeld tussen het voer en water, kunnen er een groot aantal dieren worden gewogen.. Ver- der kan een

Andere punten van kritiek zijn dat de auteur de internationale betekenis van Verolme overschat (het waren primair de Zweedse werven die de Japanse scheepsbouw lange tijd

(A,B) Representative western blotting images and quantification of E-cadherin (A) and collagen Ӏ(B) in cells transfected with the siRNA of Ezrin, AKAP95 or Yotiao in combination

Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. Journal of

From this cohort study on MMP-14 and CD44 expres- sion in ovarian cancer, we conclude that the subgroup of patients with positive expression of both MMP-14 and CD44 had type-I